Omnicell Trading Lower on 2.0x Above-Average Volume (OMCL)

Print Share

Dec 13, 2012 (Unusual volume via COMTEX) -- Omnicell shares are trading on heavy volume today, having fallen 0.0% to $15.89. Approximately 498,000 shares have changed hands today vs. average 30-day volume of 246,000 shares. Unusually high volume can signify a potential turning point or validate a breakout.

Over the past year, Omnicell has traded in a range of $12.33 to $18.15 and is now at $15.89, 29% above that low. The 200-day and 50-day moving averages have moved 0.26% lower and 0.14% higher over the past week, respectively.

Potential upside of 11.2% exists for Omnicell, based on a current level of $15.89 and analysts' average consensus price target of $17.67. The stock should discover initial support at its 200-day moving average (MA) of $14.46 and subsequent support at its 50-day MA of $14.02.

Omnicell, Inc. provides an integrated suite of clinical infrastructure and workflow automation solutions for healthcare facilities. The Company's solutions include pharmacy and supply systems, clinical reference tools, an Internet-based procurement application, and decision support tools. Omnicell sells and leases its products and services to a range of healthcare facilities.


Financial News Network Online (FNNO) is a leading provider of digital financial news content for distribution on the web. You can count on FNNO to bring you the latest market news, earnings reports, analyst comments, economic data reports and more. Visit today.

Copyright, Comtex News Network, Inc. 2012

Free Stock Analysis From Zacks

Includes Zacks Long-Term Recommendation and Target Price

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.